🇺🇸 FDA
Pipeline program

C-TIL051

CCI-2005

Phase 1 mab terminated

Quick answer

C-TIL051 for Metastatic Non Small Cell Lung Cancer is a Phase 1 program (mab) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).

Program details

Company
NEKTAR THERAPEUTICS
Indication
Metastatic Non Small Cell Lung Cancer
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials